Spastic, in medical terms, describes muscles affected by spasticity, a condition in which muscle tone is abnormally high and resistance to movement increases the faster you try to stretch or bend the affected limb. It results from damage to the parts of the brain or spinal cord that normally keep reflexes in check, and it shows up in conditions ranging from stroke and cerebral palsy to spinal cord injuries and multiple sclerosis. The word carries a straightforward clinical meaning, but the reality of living with spasticity and treating it is considerably more involved than that one-line definition suggests.
What Goes Wrong in the Nervous System
Your brain constantly sends signals down the spinal cord to fine-tune how responsive your muscles are. Some of those signals tell spinal reflexes to calm down; others ramp them up. When an injury or disease disrupts the nerve pathways carrying those signals, the balance tips. The spinal cord’s stretch reflexes, no longer held in check by the brain, become overexcitable. That overexcitability is what clinicians call spasticity.
The specific pathways involved are the corticospinal tracts, which run from the motor cortex down to the spinal cord and control voluntary movement. When those tracts are damaged, the result is part of a broader cluster of problems called upper motor neuron syndrome. Spasticity is the most recognizable feature, but the syndrome also includes weakness, loss of fine motor control, and abnormal reflexes. The key point is that the muscles themselves start out normal. The problem is upstream, in the nervous system’s failure to regulate reflex activity properly.
Conditions That Cause Spasticity
Any disease or injury that damages upper motor neurons can trigger spasticity, but a handful of conditions account for the vast majority of cases.
Cerebral palsy is the most common cause of spasticity in children, and roughly 80 percent of people with cerebral palsy experience it as their primary motor problem. The underlying damage usually happens before or around birth, when the developing brain’s motor areas or their connections to the spinal cord are injured.
Stroke is the leading cause of spasticity in adults. About a quarter of stroke survivors develop increased muscle tone within just two weeks, and the prevalence of severe spasticity tends to climb during the first year. The worse the initial arm weakness, the more likely spasticity is to become a lasting problem. Mild spasticity sometimes fades on its own, but moderate-to-severe cases rarely do.
Spinal cord injury produces spasticity through a slightly different timeline. After the initial injury there is typically a phase of “spinal shock,” during which muscles below the injury are floppy and reflexes are absent. Spasticity then gradually emerges over one to two months and usually reaches a plateau of mild-to-moderate severity within three to four months. Multiple sclerosis can also cause spasticity. In animal models of MS, researchers have found that damaged areas of the nervous system show elevated levels of the body’s own cannabinoid-like chemicals, apparently as a natural but insufficient attempt to dampen the overactive reflexes.
How Spasticity Develops and Changes After Injury
Spasticity is not an on-off switch. After a stroke, the earliest signs can appear within days, though onset typically falls somewhere between the first few days and six weeks. The neurological component of spasticity, meaning the overactive reflexes themselves, tends to peak one to three months out. After that, a second factor increasingly contributes: the muscles and connective tissues themselves begin to change.
By the three-month mark and beyond, resistance to movement is no longer purely a reflex problem. Collagen accumulates in the tissue around muscle fibers, tendons stiffen, and the muscles themselves physically shorten or remodel. At that stage, even if you could flip a switch and restore perfectly normal nerve signaling, the limb would still feel stiff because the tissue itself has changed. Understanding this two-phase process matters for treatment decisions, because therapies that target reflexes and therapies that target tissue stiffness are not the same thing.
What Spasticity Does to Muscles Over Time
Researchers used to think of spasticity as a purely neurological phenomenon, with the muscles simply along for the ride. That picture has been revised. Studies of spastic muscle show changes at both the cellular and structural level. The extracellular matrix, the scaffolding of connective tissue that surrounds muscle fibers, becomes significantly stiffer due to increased collagen content. In children with spastic cerebral palsy, for example, hamstring muscle bundles are measurably stiffer than those from children without the condition, and the increased stiffness traces to changes in that surrounding connective tissue rather than to the muscle cells themselves.
At the same time, individual muscle units in spastic limbs operate at longer-than-normal resting lengths, which puts them at a mechanical disadvantage. The combination of stiffer tissue and stretched-out muscle units multiplies the passive resistance the limb produces. This is why long-standing spasticity can lead to contractures, where joints become fixed in one position and cannot be moved through their full range even under anesthesia or when the person is completely relaxed.
Telling Spasticity Apart from Other Kinds of Stiffness
Not every stiff limb is spastic. Rigidity, the kind of increased muscle tone seen in Parkinson’s disease, feels different to the examiner and behaves differently when measured. When researchers have studied the two conditions with instruments that track resistance throughout a full range of motion, spasticity shows progressively increasing tension as the limb is moved further, while rigidity produces an elevated but constant level of resistance from start to finish. Spastic muscles also respond differently to the speed of stretching: the faster you stretch, the more resistance you feel. Rigid muscles do not follow that pattern.
This velocity dependence is central to the clinical definition. It is also why a quick exam-room stretch can sometimes miss mild spasticity if the clinician moves the limb too slowly, and why rating scales that depend on a single manual stretch have limitations.
How Clinicians Measure Spasticity
The most widely used bedside tool is the Modified Ashworth Scale, which grades resistance to passive movement on a rough scale from zero (no increase in tone) to four (the limb is rigid in flexion or extension). It is quick and requires no equipment, which explains its popularity. But it has shortcomings. A study of stroke survivors found that the scale correlated with another clinical tool (the Modified Tardieu Scale) but did not correlate significantly with electrophysiological reflex measurements, raising questions about whether it is truly measuring the neural component of spasticity or partly capturing the tissue stiffness that develops alongside it.
Newer approaches are trying to make assessment more objective. Portable devices that combine a joint-angle sensor with muscle-activity recording can compute a “spatial threshold” for the stretch reflex, essentially pinpointing the joint angle at which the reflex kicks in. Early testing of one such device showed a strong correlation with clinical scores while also providing a quantitative number that does not depend on the examiner’s subjective impression. Wearable motion sensors are another promising avenue, giving clinicians the ability to track spasticity-related movement patterns outside the clinic rather than relying on a single snapshot during an office visit.
Oral Medications
Drug treatment for spasticity generally works by dialing down excitatory signals or boosting inhibitory ones within the central nervous system. Four drugs have been approved by the FDA specifically as anti-spasticity agents: baclofen, diazepam, dantrolene sodium, and tizanidine. Several other medications with proven effects on spasticity are also used, though not formally approved for that indication.
Each of these drugs has trade-offs. Baclofen and diazepam both boost the activity of an inhibitory brain chemical called GABA, which helps quiet overactive reflexes, but both can cause drowsiness and sedation. Tizanidine works through a different pathway and tends to cause less weakness, though dry mouth and dizziness are common. Dantrolene is unique in that it acts directly on muscle tissue rather than the nervous system, reducing the force muscles can generate. That makes it useful when you want to spare cognition, but it can cause liver problems and overall muscle weakness, which is not always an acceptable trade.
The practical reality is that oral medications help take the edge off spasticity but rarely eliminate it, especially when it is severe. They also affect the whole body, not just the spastic muscles, which limits how high the dose can go before side effects become a problem.
Botulinum Toxin Injections
When spasticity is concentrated in specific muscle groups, rather than widespread throughout the body, botulinum toxin injections are the preferred treatment. The toxin works by blocking the chemical signal that nerves use to tell muscles to contract. Injected into a spastic muscle, it causes a local, reversible weakening effect that typically lasts three to four months before the nerve endings regenerate and the muscle gradually regains its previous tone.
The evidence that botulinum toxin reduces spasticity is very strong. What is equally clear, however, is that reducing spasticity does not automatically translate into better voluntary movement. A muscle that was both spastic and weak will become less spastic but will not become stronger or more coordinated after the injection. For that reason, botulinum toxin is usually combined with physical therapy aimed at taking advantage of the temporary window of reduced tone to work on stretching, strengthening, and functional training.
Injection technique matters. For deep or hard-to-reach muscles, clinicians use ultrasound or electrical stimulation guidance to make sure the toxin reaches the right spot. Research on injecting the hip flexor muscles, for instance, has shown that precise targeting of specific portions of the muscle improves outcomes.
Intrathecal Baclofen Pumps
For people with severe, widespread spasticity that does not respond adequately to oral medications, an implanted pump that delivers baclofen directly into the fluid surrounding the spinal cord can be a game-changer. A small device is placed under the skin of the abdomen and connected to a thin catheter threaded into the spinal canal. Because the drug reaches its target directly, much smaller doses produce much larger effects, and the systemic side effects like drowsiness that plague oral baclofen are largely avoided.
The benefits can be substantial. Patients report reduced spasticity and fewer spasms, improved sleep, greater independence with mobility and self-care, and less muscle pain. But the technology is not without complications. Data from a cohort of 170 people who received intrathecal baclofen therapy found a complication rate of about 0.13 events per pump-year, with roughly half the complications being device-related (catheter kinks, pump malfunctions), a third procedure-related, and a fifth drug-related (overdose or withdrawal). About two-thirds of complications required surgical intervention to fix.
Baclofen withdrawal in particular is a medical emergency. If the pump fails or the catheter disconnects, the sudden loss of the drug can cause rebound spasticity, fever, seizures, and even organ failure. Anyone with an implanted pump needs to know the warning signs and have a plan for emergency refills or troubleshooting.
Surgical Approaches
Surgery enters the picture when spasticity has caused permanent changes to muscles or joints, or when other treatments have not provided enough relief. The options fall into two broad categories: procedures aimed at the nerves and procedures aimed at the muscles and tendons.
Selective dorsal rhizotomy is a neurosurgical procedure most commonly performed in children with spastic cerebral palsy. The surgeon identifies and cuts a portion of the sensory nerve rootlets entering the spinal cord, specifically the ones carrying the abnormal reflex signals that drive spasticity in the legs. The goal is a permanent reduction in lower-limb spasticity, and outcomes are generally good in carefully selected patients, though it requires intensive physical therapy afterward to capitalize on the reduced tone.
On the orthopedic side, tendon lengthenings, tendon transfers, and joint releases can address the contractures and deformities that long-standing spasticity creates. These reconstructive procedures are well established in pediatric cerebral palsy care but are considered underutilized in adult stroke rehabilitation, where the focus tends to be on medications and therapy alone. Multidisciplinary teams that include surgeons alongside rehabilitation specialists are more likely to identify patients who could benefit from a surgical option they might otherwise never be offered.
Physical Therapy and Rehabilitation
Regardless of what medications or procedures are involved, physical therapy is the backbone of spasticity management. An umbrella review of the evidence for various physical therapy approaches in post-stroke spasticity found moderate-quality support for several techniques, including electrical nerve stimulation, neuromuscular electrical stimulation, resistance training, and lower-extremity cycling with or without functional electrical stimulation. Evidence for stretching programs, while widely recommended, is lower in quality, though stretching remains a staple because of its role in maintaining range of motion and preventing contractures.
One randomized trial comparing stretching alone against stretching combined with electrical stimulation in stroke survivors found that both groups improved, but the group receiving electrical stimulation on top of stretching showed greater gains in range of motion, functional independence, and clinical spasticity scores. This pattern, where combining therapies outperforms any single approach, is a recurring theme in spasticity rehabilitation. The best outcomes tend to come from layering treatments: medications to reduce tone, injections or pumps for targeted relief, and therapy to rebuild function.
Transcutaneous Spinal Cord Stimulation
One of the more promising newer approaches is transcutaneous spinal cord stimulation, which delivers electrical pulses to the spinal cord through electrodes placed on the skin of the back. In people with spinal cord injuries, a single session of this stimulation produced significant reductions in spasticity, clonus, and spasms that lasted at least two hours after the stimulation stopped, with large effect sizes and clinically meaningful improvements.
Subsequent research has begun to explain why it works. A study examining the spinal circuitry of people with spinal cord injuries found that 30 minutes of targeted stimulation improved both the pre-synaptic and post-synaptic inhibitory mechanisms within the spinal cord. In other words, the stimulation appears to temporarily restore some of the inhibitory braking that was lost when the spinal cord was injured. After stimulation, inhibitory function in the participants improved to levels that were no longer distinguishable from those of neurologically intact individuals. The technique is still investigational and not yet part of routine clinical care, but the combination of non-invasiveness, minimal side effects, and robust early results has generated considerable interest.
Spasticity in Children
Managing spasticity in children, particularly those with cerebral palsy, involves the same toolkit as in adults but with additional considerations. Growing bodies mean that spastic muscles can progressively deform bones and joints if tone is not managed early. A child’s brain also has more plasticity than an adult’s, which creates a larger window for therapy-driven improvement but also means that untreated spasticity can shape motor development in lasting ways.
Cerebral palsy is the most common cause of both spasticity and physical disability in childhood, and expert consensus holds that management should be multidisciplinary and should begin as early as possible. In practice, that means a team including physiotherapists, occupational therapists, orthopedic surgeons, and neurologists working together rather than sequentially. Botulinum toxin injections are commonly used starting in early childhood to manage focal problems like toe-walking or a clenched fist, and selective dorsal rhizotomy is typically performed between ages three and eight in candidates who meet specific criteria.
Sleep is an underappreciated casualty of childhood spasticity. Children with cerebral palsy experience sleep problems at far higher rates than their peers, driven by spasticity, pain, and sometimes seizures. Poor sleep in turn affects daytime function, behavior, and the child’s ability to participate in therapy. It also places a significant burden on caregivers, who are often up multiple times a night repositioning a child or responding to spasms.
When Spasticity Is Actually Useful
It is worth knowing that not all spasticity needs treating. Some people with spinal cord injuries rely on a degree of tone in their legs to stand during transfers, maintain posture in a wheelchair, or assist with circulation. Removing that tone with aggressive medication or surgery can actually make daily function worse. Clinicians experienced in spasticity management evaluate not just how much spasticity is present but how much of it is causing problems versus serving a compensatory purpose. Treatment targets the harmful excess while preserving whatever functional benefit exists, which is why a blanket “less is better” approach does not apply.
This nuance extends to rehabilitation goals more broadly. The aim is rarely to eliminate spasticity entirely. It is to reduce it enough that the person can move more comfortably, sleep better, avoid contractures, and participate more fully in their daily life. For some people that means a few stretches and occasional oral medication. For others it involves a combination of injections, a pump, surgery, and years of physical therapy. The right plan depends on which muscles are involved, how severe the tone is, what the person’s functional goals are, and how much of the stiffness is neural versus structural, a distinction that shifts over time and requires ongoing reassessment.